Wiedemann-Steiner syndrome: genes and variants
Explore variant evidence for Wiedemann-Steiner syndrome across 2 analyzed proteins (KMT2A, CHD7). Linked ClinVar records include 26 pathogenic or likely pathogenic variants, 83 variants of uncertain significance and 22 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Wiedemann-Steiner syndrome
KMT2A: Histone-lysine N-methyltransferase 2A
It maintains transcription of developmental and hematopoietic genes through chromatin-regulatory complexes and H3K4 methylation. Rearrangements create potent fusion oncoproteins that drive acute leukemias, while germline loss-of-function variants cause Wiedemann-Steiner syndrome.
25 ClinVar pathogenic / likely pathogenic and 105 uncertain variants in KMT2A have source records linked to Wiedemann-Steiner syndrome. Association strength is not clinical gene validity.
CHD7: ATP-dependent chromatin remodeler CHD7
It regulates chromatin accessibility and developmental gene programs across multiple embryonic tissues. Haploinsufficiency is the major cause of CHARGE syndrome, which can affect the eyes, heart, choanae, growth, genital development, ears, and nervous system.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CHD7 have source records linked to Wiedemann-Steiner syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): SMC1A.
Where Wiedemann-Steiner syndrome variants cluster
- KMT2A CXXC-type (positions 1147–1195): 10 of 18 ClinVar pathogenic / likely pathogenic variants, 45.0× more than its size predicts (a length-based count, not a validated hotspot).
- KMT2A PHD-type 1 (positions 1431–1482): 4 of 18 ClinVar pathogenic / likely pathogenic variants, 17.0× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Wiedemann-Steiner syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| KMT2A R1154W | 1154 | CXXC-type | Pathogenic / likely pathogenic (★★) |
| KMT2A C1155Y | 1155 | CXXC-type | Pathogenic / likely pathogenic (★★) |
| KMT2A C1158Y | 1158 | CXXC-type | Pathogenic / likely pathogenic (★★) |
| KMT2A C1189R | 1189 | CXXC-type | Pathogenic / likely pathogenic (★★) |
| KMT2A C1448Y | 1448 | PHD-type 1 | Pathogenic / likely pathogenic (★★) |
| KMT2A H1456R | 1456 | PHD-type 1 | Pathogenic / likely pathogenic (★★) |
| KMT2A G1566R | 1566 | PHD-type 3 | Pathogenic / likely pathogenic (★★) |
| KMT2A L2845P | 2845 | Pathogenic / likely pathogenic (★★) | |
| KMT2A G1181D | 1181 | CXXC-type | Pathogenic / likely pathogenic (★) |
| KMT2A G1181V | 1181 | CXXC-type | Pathogenic / likely pathogenic (★) |
| KMT2A N1183D | 1183 | CXXC-type | Pathogenic / likely pathogenic (★) |
| KMT2A C1448R | 1448 | PHD-type 1 | Pathogenic / likely pathogenic (★) |
| KMT2A R878W | 878 | Pathogenic / likely pathogenic (★) | |
| KMT2A C1434F | 1434 | PHD-type 1 | Pathogenic / likely pathogenic (★) |
| KMT2A C1936Y | 1936 | PHD-type 4 | Pathogenic / likely pathogenic (★) |
| KMT2A G1940E | 1940 | PHD-type 4 | Pathogenic / likely pathogenic (★) |
| KMT2A P2633L | 2633 | Pathogenic / likely pathogenic (★) | |
| KMT2A R3705P | 3705 | FYR C-terminal | Pathogenic / likely pathogenic (★) |
| KMT2A I3926L | 3926 | SET | Pathogenic / likely pathogenic (★) |
| KMT2A P1829T | 1829 | Pathogenic / likely pathogenic (★) | |
| KMT2A R1154Q | 1154 | CXXC-type | Pathogenic / likely pathogenic |
| KMT2A C1155R | 1155 | CXXC-type | Pathogenic / likely pathogenic |
| KMT2A C1189Y | 1189 | CXXC-type | Pathogenic / likely pathogenic |
| CHD7 L1748R | 1748 | Pathogenic / likely pathogenic | |
| KMT2A Q1587R | 1587 | PHD-type 3 | Pathogenic / likely pathogenic |
| KMT2A G2024E | 2024 | FYR N-terminal | Pathogenic / likely pathogenic |
Which prediction tools work for Wiedemann-Steiner syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 97 out of 100
- PolyPhen-2: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 94 out of 100
- MetaSVM: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 90 out of 100
- SIFT: 77 out of 100
Same protein, different disease
- CHARGE syndrome also has ClinVar records linked to CHD7 variants; they fall mostly in different places as the Wiedemann-Steiner syndrome variants (42 pathogenic / likely pathogenic).
- CHD7-related CHARGE syndrome also has ClinVar records linked to CHD7 variants; they fall mostly in different places as the Wiedemann-Steiner syndrome variants (8 pathogenic / likely pathogenic).
- Hypogonadotropic hypogonadism 5 with or without anosmia also has ClinVar records linked to CHD7 variants; they fall mostly in different places as the Wiedemann-Steiner syndrome variants (7 pathogenic / likely pathogenic).
Diseases related to Wiedemann-Steiner syndrome
- CHARGE syndrome, also linked to CHD7
- CHD7-related CHARGE syndrome, also linked to CHD7
- Joubert syndrome, also linked to CHD7
- Hypogonadotropic hypogonadism 5 with or without anosmia, also linked to CHD7
- Hypogonadotropic hypogonadism, also linked to CHD7
Frequently asked questions
Which genes have records linked to Wiedemann-Steiner syndrome?
This view contains 2 analyzed proteins: KMT2A, CHD7. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 26 pathogenic or likely pathogenic variants, 83 variants of uncertain significance and 22 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 191 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center